Skip to content

OptimizeRx OPRX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$6.84M+144%$5.13M+126%$34K+100%-$9.87M+44.9%-$15.41M+14.7%
$4.3M-1.4%$4.33M-0.1%$4.34M+2.4%$4.36M+20.6%$4.36M+44.9%
$7.23M-27.7%$6.96M-39.3%$7.94M-28.8%$8.59M-27.0%$10M-19.1%
$14.38M+117%$18.72M+283%$11.83M+855%$10.41M$6.64M
$52K-51.4%$58K-48.2%$64K-36.0%$72K-37.6%$107K+18.3%
$131K+134%$68K+115%-$258K+99.0%-$340K+98.8%-$381K+98.4%
$10.19M+155%$8M+100%$8M+154%$8M+201%$4M+54.6%
-$10.92M-125%-$8.8M-79.1%-$8.17M-124%-$8.45M-125%-$4.86M-118%
$3.6M+158%$9.99M+2,215%$3.39M$1.63M$1.4M
$14.33M+120%$18.66M+291%$11.76M+806%$10.34M$6.53M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does OptimizeRx generate?
OptimizeRx (OPRX) generated $14.4M in operating cash flow over the trailing twelve months.
What is OptimizeRx's free cash flow?
After $52.0K of capital expenditures, OptimizeRx's free cash flow was $14.3M over the trailing twelve months, up 119.5% year over year.
Where does OptimizeRx's cash flow data come from?
Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.